Case Reports
doi: 10.1007/BF00932274.
Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma
Affiliations
- PMID: 2851962
- DOI: 10.1007/BF00932274
Item in Clipboard
Case Reports
Hematometra complicating hormone replacement therapy after radiation for cervical carcinoma
Arch Gynecol Obstet.
1988.
Abstract
Hematometra developed in a patient receiving sequential estrogen-progestogen hormone replacement therapy following radiation for cervical carcinoma. Diagnosis, treatment and therapeutic recommendations are discussed.
Similar articles
-
Hematometra after radiotherapy for cervical carcinoma.Gynecol Oncol. 1997 Dec;67(3):325-7. doi: 10.1006/gyno.1997.4883. Gynecol Oncol. 1997. PMID: 9441783
-
Persistence of endometrial activity after radiation therapy for cervical carcinoma.Obstet Gynecol. 1985 Dec;66(6):805-8. Obstet Gynecol. 1985. PMID: 2999661
-
Importance of the progestogen added to the estrogen in hormone therapy.Climacteric. 2005 Dec;8(4):398-400. doi: 10.1080/13697130500345091. Climacteric. 2005. PMID: 16390775 No abstract available.
-
Hormone replacement therapy: optimising the dose and route of administration.Drugs Aging. 2002;19(11):807-18. doi: 10.2165/00002512-200219110-00001. Drugs Aging. 2002. PMID: 12428992 Review.
-
Benefits and risks of menopausal estrogen and/or progestin hormone use.Prev Med. 1988 Mar;17(2):201-23. doi: 10.1016/0091-7435(88)90064-3. Prev Med. 1988. PMID: 2843846 Review.